Detalles de la búsqueda
1.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(1): 59-68, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331154
2.
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.
Am J Respir Crit Care Med
; 181(6): 620-5, 2010 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20075387
3.
Measles-induced Acute Disseminated Encephalomyelitis in a Non-vaccinated Patient.
Eur J Case Rep Intern Med
; 7(6): 001332, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32523912
4.
Abrupt Severe Chest Pain and Vomiting: Remember to Think of a Ruptured Oesophagus (Boerhaave Syndrome).
Eur J Case Rep Intern Med
; 6(10): 001265, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31742203
5.
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Thorac Oncol
; 12(2): 383-389, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27464970
6.
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
PLoS One
; 11(3): e0147599, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27032107
7.
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).
Lung Cancer
; 50(1): 91-6, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16019107
8.
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
Clin Cancer Res
; 9(1): 143-50, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12538462
9.
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer.
J Thorac Oncol
; 10(10): 1458-67, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26309191
10.
Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy.
Int J Radiat Oncol Biol Phys
; 58(3): 758-67, 2004 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14967431
11.
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Lung Cancer
; 40(2): 191-9, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12711121
12.
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer.
J Thorac Oncol
; 8(12): 1529-37, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24389434
13.
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor.
Chest
; 141(2): 477-484, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21737491
14.
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.
J Thorac Oncol
; 6(5): 889-95, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21358346
15.
Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062.
Eur J Cancer
; 47(15): 2322-30, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21684151
16.
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.
J Thorac Oncol
; 6(11): 1930-7, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21841505
17.
The importance of accurate lymph node staging in early and locally advanced non-small cell lung cancer: an update on available techniques.
J Thorac Oncol
; 2 Suppl 2: S59-67, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17589301
Resultados
1 -
17
de 17
1
Próxima >
>>